Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.94B P/E - EPS this Y 15.60% Ern Qtrly Grth -
Income -13M Forward P/E 16.27 EPS next Y 16.20% 50D Avg Chg 1.00%
Sales 4.65B PEG 1.59 EPS past 5Y -5.36% 200D Avg Chg 11.00%
Dividend N/A Price/Book 1.95 EPS next 5Y 11.90% 52W High Chg -1.00%
Recommedations 3.00 Quick Ratio 1.01 Shares Outstanding 140.12M 52W Low Chg 57.00%
Insider Own 0.63% ROA 0.15% Shares Float 105.28M Beta 1.51
Inst Own 95.21% ROE -0.85% Shares Shorted/Prior 3.75M/4.40M Price 20.99
Gross Margin 18.97% Profit Margin -0.28% Avg. Volume 1,216,992 Target Price 22.00
Oper. Margin 0.17% Earnings Date Feb 22 Volume 5,300,387 Change 0.00%
About Covetrus, Inc.

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.

CVET Chatroom

User Image risenhoover Posted - 03/26/23

$CVET CVET / Covetrus Inc Price Target Updated https://fintel.io/sfo/us/cvet?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/25/23

$CVET CVET / Covetrus Inc Price Target Updated https://fintel.io/sfo/us/cvet?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/24/23

$CVET CVET / Covetrus Inc Price Target Updated https://fintel.io/sfo/us/cvet?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$CVET CVET / Covetrus Inc Price Target Updated https://fintel.io/sfo/us/cvet?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$CVET CVET / Covetrus Inc Price Target Updated https://fintel.io/sfo/us/cvet?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$CVET CVET / Covetrus Inc Price Target Updated https://fintel.io/sfo/us/cvet?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$CVET CVET / Covetrus Inc Price Target Updated https://fintel.io/sfo/us/cvet?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$CVET CVET / Covetrus Inc Price Target Updated https://fintel.io/sfo/us/cvet?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$CVET CVET / Covetrus Inc Price Target Updated https://fintel.io/sfo/us/cvet?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$CVET CVET / Covetrus Inc Price Target Updated https://fintel.io/sfo/us/cvet?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$CVET CVET / Covetrus Inc Price Target Updated https://fintel.io/sfo/us/cvet?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image macroaxis Posted - 1 year ago

$CVET - Option Volatility signal: Covetrus pin risk is decreasing https://www.macroaxis.com/stock-options/CVET/Covetrus?utm_source=dlvr.it&utm_medium=stocktwits

User Image otcdynamics Posted - 1 year ago

$CVET Covetrus Names Ajoy Karna as Chief Financial Officer https://www.otcdynamics.com/cvet-covetrus-names-ajoy-karna-as-chief-financial-officer

User Image STCKPRO Posted - 1 year ago

$CVET NEW ARTICLE : Covetrus Names Ajoy Karna as Chief Financial Officer https://www.stck.pro/news/CVET/38693045

User Image Stock_Titan Posted - 1 year ago

$CVET Covetrus Names Ajoy Karna as Chief Financial Officer https://www.stocktitan.net/news/CVET/covetrus-names-ajoy-karna-as-chief-financial-qhzd48klc8uj.html

User Image WebChronicleToday Posted - 1 year ago

$CVET New Press Release: Covetrus Names Ajoy Karna as Chief Financial Officer Covetrus®, a global leader in animal-health technology and services, today announced the appointment of Ajoy Karna as executive vice president and chief financial officer. Karna succeeds Matthew Foulston, who announced previously his retirement from the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221208005120/en/ Ajoy Karna, CFO, Covetrus (Photo: Business Wire) “Ajoy is a strategic and operational leader with deep global expertise in finance and driving companywide business growth,” said Benjamin Wolin, president and CEO of Covetrus. “He is a welcome addition to our leadership team, and Covetrus and our stakeholders wi (...) https://webchronicletoday.com?p=314920

User Image TheLastOneSitting Posted - 1 year ago

$ELAN big news in animal health, stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html

User Image TheLastOneSitting Posted - 1 year ago

$ABC stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. This is going to help Covetrus take even more business from MWI which is going to hurt ABC. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html

User Image TheLastOneSitting Posted - 1 year ago

$PDCO stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. This is going to help Covetrus take even more business from Patterson. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html

User Image TheLastOneSitting Posted - 1 year ago

$DXCM stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. ALRT is up and coming and will be launching an ultra low cost human CGM in 2024 that will put DXCM out of business. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html

User Image TheLastOneSitting Posted - 1 year ago

$ABT stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. This will hurt Libre 2 sales since veterinarians wont use it anymore. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html

User Image TheLastOneSitting Posted - 1 year ago

$ZTS stock ticker ALRTF ($0.07) just partnered with $CVET to sell the GluCurve Pet CGM, the first and only Continuous Glucose Monitor for diabetic pets. This will kill the AlphaTRAK 2 business. Great buying opportunity to get in on the ground floor of ALRT before they uplist to the NYSE American in Q1 https://finance.yahoo.com/news/alr-technologies-announces-co-branded-133300364.html

User Image stockilluminati Posted - 1 year ago

$CVET https://www.stockilluminati.com/cvet/news.php - Catawba Valley Engineering and Testing (CVET) Delivers Fast Report Delivery, Streamlines Processes, and Reduces Operational Costs with Agile Frameworks

User Image samchuadX Posted - 1 year ago

lawsuit scanner for $CVET https://www.lawow.org/gatto-frances-vs-ellinger-deborah-g-et-al-2022-09-14

User Image samchuadX Posted - 1 year ago

lawsuit scanner for $CVET https://www.lawow.org/pascual-v-covetrus-inc-2021-06-03/

User Image risenhoover Posted - 1 year ago

Short position in $CVET reported by Blackstone Alternative Investment Funds - Blackstone Alternative Multi-Strategy Fund Class I -> https://fintel.io/sosh/us/cvet?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=sosh

User Image stockilluminati Posted - 1 year ago

$CVET https://www.stockilluminati.com/cvet/news.php - COVE, THE WORLD'S FIRST BIODEGRADABLE WATER BOTTLE IS HITTING SHELVES ON DEC 1ST

User Image samchuadX Posted - 1 year ago

lawsuit scanner for $CVET https://www.lawow.org/rayfield-v-covetrus-inc-et-al-2022-07-25/

User Image fla Posted - 1 year ago

$CVET [15s. delayed, acc.~90%, always check] Earnings Release 2022-08-04T12:00:00: Q2: Revenue $1,217M. https://s.flashalert.me/KIxziJ

User Image fla Posted - 1 year ago

$CVET [15s. delayed, acc.~90%, always check] Earnings Release 2022-05-05T20:05:00: Q1: Revenue $1,148M. https://s.flashalert.me/DUfO5

Analyst Ratings
Stifel Hold Jun 13, 22
Barclays Equal-Weight May 26, 22
William Blair Market Perform May 25, 22
Morgan Stanley Equal-Weight May 23, 22
Raymond James Market Perform May 23, 22
Goldman Sachs Sell Aug 25, 22
Barclays Overweight May 9, 22
Raymond James Outperform May 6, 22
Morgan Stanley Equal-Weight Nov 18, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wolin Benjamin President and CEO President and CEO Aug 09 Sell 20.81 10,584 220,253 194,488 08/11/22
Manoff Mark Jeffrey Director Director May 17 Option 0 24,089 30,377 05/17/21
Manoff Mark Jeffrey Director Director May 17 Sell 25.9 11,500 297,850 18,877 05/17/21
FINER DUSTIN Chief Administrative.. Chief Administrative Officer Feb 10 Sell 37.11 5,260 195,199 22,101 02/10/21
Wolin Benjamin President and CEO President and CEO Jan 27 Sell 37.98 5,556 211,017 69,916 01/27/21
Providenti Anthony C. Jr. See Remarks See Remarks Jan 19 Option 0 10,218 20,540 01/19/21
Providenti Anthony C. Jr. See Remarks See Remarks Jan 19 Sell 36.79 5,000 183,950 11,901 01/19/21
FINER DUSTIN Chief Administrative.. Chief Administrative Officer Dec 21 Sell 28.51 5,260 149,963 15,485 12/21/20
Wraight Georgina See Remarks See Remarks Oct 01 Option 8.6 10,000 86,000 12,237 10/01/20
Wraight Georgina See Remarks See Remarks Oct 01 Sell 25 10,000 250,000 2,237 10/01/20